We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Pharmacovigilance system requirements
The Intellectual Property Office (IPO) is the official UK government body responsible for intellectual property (IP) rights including patents, designs, trade marks and copyright. IPO is an executive agency, sponsored by the Department for Science, Innovation and Technology , supported...
The Intellectual Property Office offers different methods of accelerating the processing of your patent application.
Guidance for organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA, covering the approval of paper documents when working from home
Guidance to help organisations choose a monitoring approach for stack emissions to air that meets Environment Agency and MCERTS requirements (formerly part of M2).
When tests to detect COVID-19 are commonly used (use cases) and what to consider when deciding which type of test to employ.
Guidance for those producing, processing, consuming, importing or exporting chemicals covered by the Chemical Weapons Convention (CWC)
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Information to help you protect, manage and enforce your intellectual property (IP) rights in China.
A list of links to coronavirus (COVID-19) information provided by Ofqual-recognised awarding organisations.
Use form C88 (status) as proof of authorisation to import or export for the country of destination.
Look up a trade mark to see if something identical or similar to your brand is already registered.
The MHRA is part of the Access Consortium along with the Therapeutic Goods Administration, Health Canada, Health Sciences Authority of Singapore and Swissmedic.
This guidance specifies the standards for the continuous monitoring and sampling of stack emissions.
Nigeria is subject to regional controls governing small arms and light weapons.
Development of a standard approach for AI and autonomy in networked multi-sensor systems in security and defence.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.